Byron Nash Renal Medullary Carcinoma Awareness Act of 2023
Source: Congress.gov ·
299 words in original text
What This Bill Does
This bill changes Medicaid rules to include education about renal medullary carcinoma (a type of kidney cancer) alongside education about other serious health conditions. The bill applies specifically to people receiving Medicaid who have sickle cell disease (an inherited blood disorder).
Who It Affects
- Individuals with sickle cell disease who receive Medicaid medical assistance
- State Medicaid programs
- Healthcare providers participating in Medicaid
Key Provisions
- Medicaid must provide incentives for education about the risk of renal medullary carcinoma to people with sickle cell disease who receive medical assistance (Sec. 2(a))
What Changes
The bill adds "renal medullary carcinoma" to the list of health conditions for which Medicaid can provide educational incentives, placing it alongside stroke and other conditions already listed in federal law.
Important Definitions
None defined in the bill text.
Effective Date
The amendments apply to items and services furnished on or after the date the bill becomes law. (Sec. 2(b))
Important: This plain English summary was generated by AI and is provided for informational purposes only.
It is not legal advice. Always consult the official bill text on Congress.gov
or a qualified attorney for legal matters.